|
gptkbp:instance_of
|
gptkb:drug
|
|
gptkbp:affects
|
progesterone receptors
|
|
gptkbp:appointed_by
|
oral tablet
|
|
gptkbp:approves
|
gptkb:philosopher
gptkb:1986
gptkb:1996
gptkb:FDA
|
|
gptkbp:brand
|
gptkb:Ortho_Tri-Cyclen
gptkb:Yasmin
gptkb:Cryselle
gptkb:Loestrin_24_Fe
gptkb:Necon_10/11
|
|
gptkbp:can_be_used_with
|
gptkb:ethinyl_estradiol
|
|
gptkbp:class
|
progestin
|
|
gptkbp:clinical_trial
|
contraception
|
|
gptkbp:composed_of
|
gptkb:chemical_compound
|
|
gptkbp:contraindication
|
gptkb:healthcare_organization
liver disease
|
|
gptkbp:developed_by
|
gptkb:Organon
|
|
gptkbp:dosage_form
|
0.18 mg
|
|
gptkbp:excretion
|
urine
|
|
gptkbp:formulation
|
combination pill
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
norgestimate
|
|
gptkbp:ingredients
|
C20 H25 N3 O3 S
C22 H29 N O3
|
|
gptkbp:interacts_with
|
antibiotics
|
|
gptkbp:is_atype_of
|
G03 A C07
|
|
gptkbp:is_available_on
|
gptkb:tablet
|
|
gptkbp:is_used_for
|
contraception
hormonal contraception
|
|
gptkbp:lifespan
|
8 hours
|
|
gptkbp:marketed_as
|
gptkb:Johnson_&_Johnson
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:related_to
|
gptkb:ethinylestradiol
progesterone
|
|
gptkbp:side_effect
|
headache
nausea
weight gain
breast tenderness
mood changes
|
|
gptkbp:type_of
|
108271-55-7
35113-60-3
|
|
gptkbp:used_in
|
oral contraceptives
|
|
gptkbp:bfsParent
|
gptkb:Ortho_Tri-Cyclen
|
|
gptkbp:bfsLayer
|
4
|